TY - JOUR
T1 - Recomendaciones del Comité Español del Antibiograma (COESANT) para la selección de antimicrobianos y sus concentraciones en el estudio in vitro de la sensibilidad con métodos automáticos
AU - Cantón, Rafael
AU - Oliver, Antonio
AU - Alós, Juan Ignacio
AU - de Benito, Natividad
AU - Bou, Germán
AU - Campos, José
AU - Calvo, Jorge
AU - Canut, Andrés
AU - Castillo, Javier
AU - Cercenado, Emilia
AU - Domínguez, Maria Ángeles
AU - Fernández-Cuenca, Felipe
AU - Guinea, Jesús
AU - Larrosa, Nieves
AU - Liñares, Josefina
AU - López-Cerero, Lorena
AU - López-Navas, Antonio
AU - Marco, Francesc
AU - Mirelis, Beatriz
AU - Moreno-Romo, Miguel Ángel
AU - Morosini, María Isabel
AU - Navarro, Ferran
AU - Oteo, Jesús
AU - Pascual, Álvaro
AU - Pérez-Trallero, Emilio
AU - Pérez-Vázquez, María
AU - Soriano, Alex
AU - Torres, Carmen
AU - Vila, Jordi
AU - Martínez-Martínez, Luis
N1 - Funding Information:
This document did not have any specific funding. COESANT activities are partially funded by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) and the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC).
Funding Information:
Scientific and research activities of RC, AO, GB, JC, JC, MAD, FFC, LLC, FM, MIM, JOI, AP, MPV, JV and LM-M are Supported by Plan Nacional de I+D+i 2013–2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía, Industria y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI) (RD16/0016/0001; RD16/0016/0002; RD16/0016/0003; RD16/0016/0004; RD16/0016/0005; RD16/0016/0006; RD16/0016/0007; RD16/0016/0008; RD16/0016/0010; RD16/0016/0011; RD16CIII/0004/002) – cofinanced by European Development Regional Fund “A way to achieve Europe”, Operative program Intelligent Growth 2014–2020 and of CT by Plan Nacional de I+D+i 2013–2016, Ministerio de Economía, Industria y Competitividad, Spain (SAF2016-76571-R).
Publisher Copyright:
© 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
PY - 2020/4
Y1 - 2020/4
N2 - Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including antimicrobial agents and selecting concentrations in these systems. Under the patronage of the Spanish Antibiogram Committee (Comité Español del Antibiograma, COESANT) and the Study Group on Mechanisms of Action and Resistance to Antimicrobial Agents (GEMARA) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and aligned with the Spanish National Plan against Antimicrobial Resistance (PRAN), a group of experts have updated this document. The main modifications from the previous version comprise the inclusion of new antimicrobial agents, adaptation of the ranges of concentrations to cover the EUCAST breakpoints and epidemiological cut-off values (ECOFFs), and the inference of new resistance mechanisms. This proposal should be considered by different manufacturers and users when designing new panels or cards. In addition, recommendations for selective reporting are also included. With this approach, the implementation of EUCAST breakpoints will be easier, increasing the quality of antimicrobial susceptibility testing data and their microbiological interpretation. It will also benefit epidemiological surveillance studies as well as the clinical use of antimicrobials aligned with antimicrobial stewardship programs.
AB - Automated antimicrobial susceptibility testing devices are widely implemented in clinical microbiology laboratories in Spain, mainly using EUCAST (European Committee on Antimicrobial Susceptibility Testing) breakpoints. In 2007, a group of experts published recommendations for including antimicrobial agents and selecting concentrations in these systems. Under the patronage of the Spanish Antibiogram Committee (Comité Español del Antibiograma, COESANT) and the Study Group on Mechanisms of Action and Resistance to Antimicrobial Agents (GEMARA) from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), and aligned with the Spanish National Plan against Antimicrobial Resistance (PRAN), a group of experts have updated this document. The main modifications from the previous version comprise the inclusion of new antimicrobial agents, adaptation of the ranges of concentrations to cover the EUCAST breakpoints and epidemiological cut-off values (ECOFFs), and the inference of new resistance mechanisms. This proposal should be considered by different manufacturers and users when designing new panels or cards. In addition, recommendations for selective reporting are also included. With this approach, the implementation of EUCAST breakpoints will be easier, increasing the quality of antimicrobial susceptibility testing data and their microbiological interpretation. It will also benefit epidemiological surveillance studies as well as the clinical use of antimicrobials aligned with antimicrobial stewardship programs.
KW - Antibiogram
KW - Automated susceptibility testing systems
KW - MICs
KW - Minimum antimicrobial concentrations
UR - http://www.scopus.com/inward/record.url?scp=85062811827&partnerID=8YFLogxK
U2 - 10.1016/j.eimc.2019.01.017
DO - 10.1016/j.eimc.2019.01.017
M3 - Artículo de revisión
C2 - 30878313
AN - SCOPUS:85062811827
SN - 0213-005X
VL - 38
SP - 182
EP - 187
JO - Enfermedades Infecciosas y Microbiologia Clinica
JF - Enfermedades Infecciosas y Microbiologia Clinica
IS - 4
ER -